Cargando…

Diagnosis and Treatment of Alcoholic Liver Disease and Its Complications

Alcoholic liver disease (ALD) is a serious and potentially fatal consequence of alcohol use. The diagnosis of ALD is based on drinking history, physical signs and symptoms, and laboratory tests. Treatment strategies for ALD include lifestyle changes to reduce alcohol consumption, cigarette smoking,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marsano, Luis S., Mendez, Christian, Hill, Daniell, Barve, Shirish, Mcclain, Craig J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Institute on Alcohol Abuse and Alcoholism 2003
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668876/ https://www.ncbi.nlm.nih.gov/pubmed/15535453

Ejemplares similares

Cytokines and Alcoholic Liver Disease
por: McClain, Craig J., et al.
Publicado: (1997)

cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease
por: Elnagdy, Mohamed, et al.
Publicado: (2020)

Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice
por: Chen, Wei-Yang, et al.
Publicado: (2016)

Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease In HIV-Infected Patients
por: Barve, Shirish, et al.
Publicado: (2010)

Elevated Linoleic Acid (A Pro-Inflammatory PUFA) and Liver Injury in a Treatment Naive HIV-HCV Co-Infected Alcohol Dependent Patient
por: Vatsalya, Vatsalya, et al.
Publicado: (2016)

Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV
por: Moghe, Akshata, et al.
Publicado: (2017)

Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences
por: Joshi-Barve, Swati, et al.
Publicado: (2015)

Development, Prevention, and Treatment of Alcohol-Induced Organ Injury: The Role of Nutrition
por: Barve, Shirish, et al.
Publicado: (2017)

Alcoholic Liver Disease: Update on the Role of Dietary Fat
por: Kirpich, Irina A., et al.
Publicado: (2016)

Metagenomic Analyses of Alcohol Induced Pathogenic Alterations in the Intestinal Microbiome and the Effect of Lactobacillus rhamnosus GG Treatment
por: Bull-Otterson, Lara, et al.
Publicado: (2013)

Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice
por: Singhal, Richa, et al.
Publicado: (2021)

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms
por: Li, Fengyuan, et al.
Publicado: (2016)

Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury
por: Ghare, Smita S., et al.
Publicado: (2023)

Microbiome dysbiosis and alcoholic liver disease(☆)
por: Li, Fengyuan, et al.
Publicado: (2019)

Exosome‐Like Nanoparticles From Lactobacillus rhamnosus GG Protect Against Alcohol‐Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice
por: Gu, Zelin, et al.
Publicado: (2021)

Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies
por: Montoya-Durango, Diego, et al.
Publicado: (2023)

Interaction of Heavy Drinking Patterns and Depression Severity Predicts Efficacy of Quetiapine Fumarate XR in Lowering Alcohol Intake in Alcohol Use Disorder Patients
por: Vatsalya, Vatsalya, et al.
Publicado: (2020)

Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease
por: Warner, Jeffrey Barr, et al.
Publicado: (2022)

Management of Alcohol-Related Liver Disease and Its Complications
por: Cabezas, Joaquín
Publicado: (2022)

Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients
por: Winrich, Evan J., et al.
Publicado: (2022)

Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice
por: Zhao, Cuiqing, et al.
Publicado: (2019)

Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury
por: Donde, Hridgandh, et al.
Publicado: (2019)

Rodent Models of Alcoholic Liver Disease: Role of Binge Ethanol Administration
por: Ghosh Dastidar, Shubha, et al.
Publicado: (2018)

Novel Liposomal Rolipram Formulation for Clinical Application to Reduce Emesis
por: Gobejishvili, Leila, et al.
Publicado: (2022)

Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023)

Molecular Basis and Current Treatment for Alcoholic Liver Disease
por: Miranda-Mendez, Alejandra, et al.
Publicado: (2010)

Metabolic Profiling of Bile Acids in the Urine of Patients with Alcohol‐Associated Liver Disease
por: He, Liqing, et al.
Publicado: (2021)

Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
por: Yin, Xunzhe, et al.
Publicado: (2023)

Diagnosis and Management of Alcoholic Liver Disease
por: Dugum, Mohannad, et al.
Publicado: (2015)

Metabolic Analysis of Nucleosides/Bases in the Urine and Serum of Patients with Alcohol-Associated Liver Disease
por: He, Liqing, et al.
Publicado: (2022)

Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice
por: Liu, Yunhuan, et al.
Publicado: (2020)

Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
por: Oh, Hyunwoo, et al.
Publicado: (2016)

Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
por: Yepmo, Melissa, et al.
Publicado: (2022)

Noninvasive diagnosis in alcohol‐related liver disease
por: Hadefi, Alia, et al.
Publicado: (2020)

Role of Nutrition in Alcoholic Liver Disease: Summary of the Symposium at the ESBRA 2017 Congress
por: Kharbanda, Kusum K., et al.
Publicado: (2018)

Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy
por: Subramaniyan, Vetriselvan, et al.
Publicado: (2021)

Transient Elastography in the Diagnosis of Pediatric Non-alcoholic Fatty Liver Disease and Its Subtypes
por: Yang, Lin, et al.
Publicado: (2022)

Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice
por: Warner, Jeffrey B., et al.
Publicado: (2022)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

Hepatic Encephalopathy— A Serious Complication of Alcoholic Liver Disease
por: Butterworth, Roger F.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_mfeg5dncovkqpmm654tuc05pab